Simulation and Matching-Based Approaches for Indirect Comparison of Treatments K. Jack IshakIrina ProskorovskyAgnes Benedict Leading Article 21 March 2015 Pages: 537 - 549
A Practical Guide for Using Registry Data to Inform Decisions About the Cost Effectiveness of New Cancer Drugs: Lessons Learned from the PHAROS Registry Hedwig M. BlommesteinMargreet G. FrankenCarin A. Uyl-de Groot Practical Application Open access 03 February 2015 Pages: 551 - 560
Pharmacological Management of Chronic Lower Back Pain: A Review of Cost Effectiveness Marion HaasRichard De Abreu Lourenco Review Article 22 January 2015 Pages: 561 - 569
Welfarism Versus Extra-Welfarism: Can the Choice of Economic Evaluation Approach Impact on the Adoption Decisions Recommended by Economic Evaluation Studies? James BuchananSarah Wordsworth Review Article 14 February 2015 Pages: 571 - 579
Cost Effectiveness of Dipeptidyl Peptidase-4 Inhibitors for Type 2 Diabetes Jinsong GengHao YuYingyao Chen Systematic Review 04 March 2015 Pages: 581 - 597
Cost-Utility Analysis of a Medication Review with Follow-Up Service for Older Adults with Polypharmacy in Community Pharmacies in Spain: The conSIGUE Program Francisco Jódar-SánchezAmaia Malet-LarreaShalom I. Benrimoj Original Research Article 15 March 2015 Pages: 599 - 610
Erratum to: Cost Effectiveness of Oromucosal Cannabis-Based Medicine (Sativex®) for Spasticity in Multiple Sclerosis Lanting LuHilary PearceKen Stein Erratum 24 April 2015 Pages: 611 - 611